- Home
- CRON vs SYRE Comparison
CRON vs SYRE Comparison
Compare CRON & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRON | SYRE |
|---|---|---|
| Founded | N/A | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 961.2M | 1.1B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | CRON | SYRE |
|---|---|---|
| Price | $2.82 | $34.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $55.50 |
| AVG Volume (30 Days) | ★ 1.9M | 699.8K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $132,357,000.00 | N/A |
| Revenue This Year | $19.67 | N/A |
| Revenue Next Year | $30.56 | N/A |
| P/E Ratio | $29.63 | ★ N/A |
| Revenue Growth | ★ 19.00 | N/A |
| 52 Week Low | $1.60 | $10.91 |
| 52 Week High | $3.16 | $34.98 |
Technical Indicators
Market Signals| Indicator | CRON | SYRE |
|---|---|---|
| Relative Strength Index (RSI) | 71.81 | 75.81 |
| Support Level | $2.40 | $28.16 |
| Resistance Level | $2.55 | $34.98 |
| Average True Range (ATR) | 0.12 | 1.95 |
| MACD | 0.03 | 0.57 |
| Stochastic Oscillator | 83.46 | 96.99 |
Price Performance
Historical ComparisonAbout CRON Cronos Group Inc.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.